Lisanti Capital Growth’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-64,545
Closed -$10.5M 126
2023
Q3
$10.5M Buy
64,545
+2,100
+3% +$369K 1.66% 11
2023
Q2
$11.4M Sell
62,445
-34,210
-35% -$4.92M 1.59% 9
2023
Q1
$12.9M Sell
96,655
-12,145
-11% -$1.43M 1.8% 10
2022
Q4
$8.63M Buy
108,800
+68,500
+170% +$4.83M 1.18% 30
2022
Q3
$2.44M Buy
+40,300
New +$2.6M 0.33% 97
2021
Q3
Sell
-128,301
Closed -$5.19M 130
2021
Q2
$5.19M Buy
+128,301
New +$5.32M 0.64% 68
2018
Q1
Sell
-18,210
Closed -$523K 110
2017
Q4
$523K Buy
+18,210
New +$573K 0.3% 106

Other funds holding ACLS

Lisanti Capital Growth's ACLS Position: Q4 2023 in Review

Lisanti Capital Growth sold out of Axcelis (ACLS) in Q4 2023, closing a stake of 64,545 shares — an estimated $10.5M sold.

Lisanti Capital Growth first reported a position in ACLS in Q4 2017 and held it in 7 quarters. The position peaked at $12.9M in Q1 2023. 421 funds tracked by Wall St. Rank hold ACLS as of Q4 2023.

  • Lisanti Capital Growth reported no remaining Axcelis position as of Q4 2023 after selling out during the quarter.
  • Lisanti Capital Growth sold 64,545 Axcelis shares in Q4 2023, an estimated $10.5M.
  • Lisanti Capital Growth first reported a position in Axcelis in Q4 2017 and held it in 7 quarters.
  • Lisanti Capital Growth's Axcelis position peaked at $12.9M in Q1 2023.
  • 421 funds tracked by Wall St. Rank held Axcelis as of Q4 2023.

Based on Lisanti Capital Growth's 13F filing for Q4 2023, filed 6 Feb 2024.